RE:RE:RE:RE:RE:Prothena and Management's ReportingMeanwhile, if Bioasis is not fully reporting material events, circumstances and technology limitations, and is using language that purposefully obscures the status of Bioasis and xB3, would regulators be interested in that? Does the Prothena situation suggest deeper problems?
Would more transparency be nice? Sure. But this is not uncommon with small biotechs. They are more opaque when possible suitors are kicking the tires, until there is solid news to report. This never bothered you before. At least not nearly to this extent.
Purposely obsure? Deeper problems? Regulators? I had to scroll up to double check who I'm responding to. You're sounding like POOF with his FUD questions. It makes one wonder if your soured relationship with Bioasis has affected your objectivity.